Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Naert T, Tulkens D, Van Nieuwenhuysen T, Przybyl J, et al. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping. Proc Natl Acad Sci U S A 2021;118.
PMID: 34789568


Privacy Policy